Parameters related to the application of recombinant ovine interleukin-1β as an adjuvant
- 1 January 1995
- Vol. 13 (14) , 1277-1287
- https://doi.org/10.1016/0264-410x(95)00074-b
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Production and in vivo use of recombinant ovine IL-1β as an immunological adjuvantVaccine, 1994
- Recombinant cytokines as immunological adjuvantsImmunology & Cell Biology, 1993
- Immunopotentiation of bovine respiratory disease virus vaccines by interleukin-1 β and interleukin-2Veterinary Immunology and Immunopathology, 1993
- Non-inflammatory peptide fragments of IL1 as safe new-generation adjuvantsResearch in Immunology, 1992
- Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins.The Journal of Experimental Medicine, 1991
- Interleukin-1 derived synthetic peptide as an added co-adjuvant in vaccine formulationsVaccine, 1991
- Autoantibodies to cytokines - friends or foes?Immunology Today, 1990
- Antitumor activity of recombinant interleukin 6 in mice.The Journal of Experimental Medicine, 1990
- Differential activity of interleukin 1α and interleukin 1β in the stimulation of the immune response in vivoEuropean Journal of Immunology, 1990
- A mutant protein of human interleukin-1ß with immunostimulatory but not pyrogenic potencyLife Sciences, 1990